Results 61 to 70 of about 44,621 (163)

Cell-intrinsic PD-L1 ablation sustains effector CD8+ T cell responses and promotes antitumor T cell therapy

Cell Reports
Summary: Adoptive cell therapies are emerging forms of immunotherapy that reprogram T cells for enhanced antitumor responses. Although surface programmed cell death-ligand 1 (PD-L1)/programmed cell death protein 1 (PD-1) engagement inhibits antitumor ...
Xinran Wang, Lu Lu, Xiaochuan Hong, Lingling Wu, Chao Yang, You Wang, Wenwen Li, Yuanqin Yang, Dongqing Cao, Wen Di, Liufu Deng   +10 more
doaj   +1 more source

A good start of immunotherapy in esophageal cancer

Cancer Medicine, 2019
Considering the benefits of immunotherapy in advanced melanoma, non–small cell lung cancer, renal cell carcinoma, bladder cancers, and refractory Hodgkin lymphoma, we begin to consider whether immunotherapy is effective for esophageal cancer, which is ...
Qian Zhao, Jinming Yu, Xue Meng
doaj   +1 more source

Promises and Pitfalls of Next-Generation Treg Adoptive Immunotherapy. [PDF]

Cancers (Basel), 2023
Christofi P, Pantazi C, Psatha N, Sakellari I, Yannaki E, Papadopoulou A.   +5 more
europepmc   +1 more source

Adoptive Immunotherapy and High-Risk Myeloma. [PDF]

Cancers (Basel), 2023
Duane C, O'Dwyer M, Glavey S.
europepmc   +1 more source

CD103+CD8+ tissue‐resident memory T lymphocytes of melanoma boost anti‐tumour immunity and predict immunotherapy outcomes

Clinical and Translational Medicine
Background Immunotherapy has revolutionised melanoma treatment, providing significant clinical benefits by reactivating the anti‐tumour immune system. CD8+ tissue‐resident memory T lymphocytes (CD8+ TRM) have emerged as crucial mediators of anti‐tumour ...
Tianyi Zhang, Junquan Song, Yinlam Li, Kangjie Shen, Jiangying Xuan, Yuan Gao, Lili Lu, Zhi Pang, Lu Wang, Yang Yang, Zixu Gao, Qianrong Hu, Yu Zhu, Chenlu Wei, Shaoluan Zheng, Rongkui Luo, Yingyong Hou, Yuhong Zhou, Chuanyuan Wei, Jianying Gu   +19 more
doaj   +1 more source

Adoptive Immunotherapy for Prophylaxis and Treatment of Cytomegalovirus Infection. [PDF]

Viruses, 2022
Ouellette CP.
europepmc   +1 more source

Adoptive Immunotherapy: A Human Pluripotent Stem Cell Perspective. [PDF]

Cells Tissues Organs, 2023
Jin G, Chang Y, Harris JD, Bao X.
europepmc   +1 more source

Current Status and Research Progress of Immunotherapy for Colorectal Cancer

Zhongliu Fangzhi Yanjiu
Colorectal cancer (CRC) seriously threatens people's health and safety, with high incidence and mortality rates. Surgery combined with radiotherapy and chemotherapy is the main treatment method for CRC at present, but the results are unsatisfactory.
Xiangchen ZHANG, Xinjun LIANG, Shaozhong WEI   +2 more
doaj   +1 more source

Natural killer cells modified with a Gpc3 aptamer enhance adoptive immunotherapy for hepatocellular carcinoma. [PDF]

Discov Oncol, 2023
Zheng Y, Lai Z, Wang B, Wei Z, Zeng Y, Zhuang Q, Liu X, Lin K.   +7 more
europepmc   +1 more source

Adoptive Immunotherapy [PDF]

, 2020
openaire   +1 more source